SPRB
Spruce Biosciences, Inc.
45.40$
-0.6%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +10.2% | +41.9% | -6.1% | -30.7% | -19.6% | -62.6% | +15.8% | +0.0% | -100.0% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | +5.6% | +1.1% | -8.3% | +17.0% | +8,696.1% | -98.8% | +8,160.7% | +32.5% | +12.1% | -99.9% | -5.9% | -6.3% | +53,833.3% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -6.6% | -30.3% | -19.6% | -62.6% | – | – | – | – | – | – | – | – | |
| – | +0.0% | -28.1% | +35.2% | +61.9% | +22.8% | +37.2% | -25.2% | +15.5% | +35.8% | -5.6% | -27.3% | +36.0% | +6.5% | -3.0% | +0.5% | +32.5% | +12.1% | +2.8% | -17.7% | -7.1% | -21.6% | -19.0% | +227.4% | -49.5% | -96.0% | +1,065.3% | -18.1% | +84.6% | +60.6% | – | |
| – | +0.0% | -40.9% | -37.4% | +82.9% | +39.0% | +146.2% | +40.8% | +23.1% | -16.4% | +7.6% | +3.0% | +12.1% | -12.5% | -2.0% | +18.3% | +5.5% | -12.7% | +7.5% | -8.8% | +46.3% | -17.6% | -2.8% | -4.1% | +10.3% | -14.6% | +3.1% | +117.4% | -36.9% | -1.4% | – | |
| – | +0.0% | -30.3% | +22.2% | +63.8% | +24.5% | +49.6% | -12.8% | +17.8% | +19.3% | -2.7% | -19.9% | +28.4% | +1.3% | -2.7% | -71.7% | +5.5% | -12.7% | +455.7% | -16.1% | +4.3% | -20.4% | -14.0% | +147.5% | -41.5% | -81.4% | +205.7% | +34.9% | +8.0% | +37.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | +1,100.0% | +23.3% | +24.3% | -14.1% | -1.3% | +14.1% | -10.1% | +10.0% | +0.0% | -1.1% | +8.0% | +17.0% | +17.3% | +1.6% | -3.1% | -6.3% | -10.9% | -8.5% | -14.4% | -14.5% | -21.1% | -35.7% | -19.4% | -34.5% | -68.4% | +11,133.3% | +62.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | +213.0% | +56.9% | +12.4% | +2.4% | +10.8% | -25.0% | -7.4% | +29.0% | -17.1% | -72.9% | +582.8% | -178.8% | – | – | – | -101.4% | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.